N. Rogers

发表

Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles.

M. Hussain, B. Aungst, N. J. Rogers, 1990, Journal of pharmaceutical sciences.

Site Dependence of Absorption-Promoting Actions of Laureth-9, Na Salicylate, Na2EDTA, and Aprotinin on Rectal, Nasal, and Buccal Insulin Delivery

B. Aungst, N. J. Rogers, N. Rogers, 1988, Pharmaceutical Research.

Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of a bile salt absorption promoter.

E. Shefter, B. Aungst, N. J. Rogers, 1988, The Journal of pharmacology and experimental therapeutics.

Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides

E. Shefter, B. Aungst, N. J. Rogers, 1986 .

Atherogenic levels of low-density lipoprotein increase endocytotic activity in cultured human endothelial cells.

K. Pritchard, J. Holland, N. J. Rogers, 1992, The American journal of pathology.

Bradykinin induces superoxide anion release from human endothelial cells

K. Pritchard, M. Stemerman, M. Pappolla, 1990, Journal of cellular physiology.

Perturbation of cultured human endothelial cells by atherogenic levels of low density lipoprotein.

K. Pritchard, J. Holland, N. J. Rogers, 1988, The American journal of pathology.

Amphiphilic vehicles improve the oral bioavailability of a poorly soluble HIV protease inhibitor at high doses

M. Hussain, B. Aungst, Nhung H. A. Nguyen, 1997 .

Effects of plasma protein binding displacement on the pharmacokinetics, tissue and tumor concentrations and efficacy of brequinar, a highly protein-bound antitumor agent.

B. Aungst, B. Dusak, J. Blake, 1990, The Journal of pharmacology and experimental therapeutics.

Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery

B. Aungst, N. J. Rogers, N. Rogers, 1989 .

Prodrugs to Improve the Oral Bioavailability of a Diacidic Nonpeptide Angiotensin II Antagonist

M. Hussain, H. Saitoh, B. Aungst, 1995, Pharmaceutical Research.